GlobalData on MSN

HUTCHMED begins Phase III segment of metastatic PDAC treatment trial

HUTCHMED has commenced the Phase III stage of its ongoing Phase II/III clinical trial assessing the combination of ...

HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that it has initiated the Phase III ...
PharmaTimes

HUTCHMED begins phase 3 stage of pancreatic cancer trial

HUTCHMED has advanced its ongoing study of surufatinib and camrelizumab for treatment‑naïve metastatic pancreatic ductal ...
TipRanks on MSN

HUTCHMED advances surufatinib combo into phase III trial for metastatic pancreatic cancer in China

HUTCHMED (China) ( ($HK:0013) ) just unveiled an update. HUTCHMED has initiated the Phase III stage of an ongoing Phase II/III clinical trial in ...

Theriva™ Biologics Announces Positive Scientific Advice from the European Medicines Agency (EMA) on the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the ...

Propanc Biopharma Publishes Impact of Proenzymes on Pancreatic Ductal Adenocarcinoma Fibroblasts in Peer Reviewed Journal

Propanc Biopharma, Inc. (Nasdaq: PPCB) is developing a novel approach to preventing cancer recurrence and metastasis by targeting and eradicating cancer stem cells through proenzyme activation. The ...
BMJ Case Reports

Duodenal metastases from lung adenocarcinoma causing gastrointestinal bleeding: a rare aetiology

Gastrointestinal metastases from primary lung adenocarcinoma are rare, with only a few reported cases of gastrointestinal bleeding caused by such metastases. Among the cancers that most commonly ...